BridgeRNAton: Scandalously Precise DNA Matchmaking by Non-Coding RNAs.

  • Abstract
  • Literature Map
  • Similar Papers
Abstract
Translate article icon Translate Article Star icon
Take notes icon Take Notes

BridgeRNAton: Scandalously Precise DNA Matchmaking by Non-Coding RNAs.

Similar Papers
  • Research Article
  • 10.2144/000114615
BioSpotlight / Citations
  • Dec 1, 2017
  • BioTechniques
  • Patrick C.H Lo + 1 more

BioSpotlight / Citations

  • Book Chapter
  • Cite Count Icon 3
  • 10.1016/b978-0-323-91722-3.00013-0
Chapter 7 - RNAi based approaches for abiotic and biotic stresses tolerance of crops
  • Jan 1, 2023
  • Plant Small RNA in Food Crops
  • Neha Patwa + 3 more

Chapter 7 - RNAi based approaches for abiotic and biotic stresses tolerance of crops

  • Research Article
  • Cite Count Icon 176
  • 10.1038/sj.emboj.7600465
The mitochondrial RNA polymerase contributes critically to promoter specificity in mammalian cells
  • Nov 4, 2004
  • The EMBO Journal
  • Martina Gaspari + 3 more

Initiation of transcription in mammalian mitochondria depends on three proteins: mitochondrial RNA polymerase (POLRMT), mitochondrial transcription factor A (TFAM) and mitochondrial transcription factor B2 (TFB2M). We show here that the recombinant mouse and human transcription machineries are unable to initiate transcription in vitro from the heterologous light-strand promoter (LSP) of mitochondrial DNA. This species specificity is dependent on the interaction of TFAM and POLRMT with specific distal and proximal promoter elements. A sequence element localized from position -1 to -2 relative to the transcription start site in LSP functionally interacts with POLRMT. The POLRMT/TFB2M heterodimer is unable to interact with promoter elements and initiate even abortive transcription in the absence of TFAM. TFAM is thus an integral part of the mammalian transcription machinery, and we propose that TFAM induces a structural change of the promoter that is required for POLRMT-dependent promoter recognition.

  • Research Article
  • Cite Count Icon 4
  • 10.11406/rinketsu.56.2056
Recent advancements in molecular cytogenetics for hematological malignancies: identification of novel PVT1 fusion genes
  • Oct 1, 2015
  • Rinsho Ketsueki
  • Masafumi Taniwaki

Specific chromosomal abnormalities are of diagnostic and prognostic relevance as well as providing clues for the identification of causative genes in patients with hematological malignancies. Genomic array (GA) is a powerful tool for identifying both microdeletion and precise DNA breakpoints in the genes of interest. For example, GA was able to detect CDKN2A and CDKN2B deletions in a small region only 69kb in size at 9p21 that were frequently found in patients with double-hit lymphoma. Using GA combined with spectral karyotyping, fluorescence in situ hybridization, and RT-PCR, we have identified a novel PVT1 rearrangement at 8q24 which were partnered with NBEA and WWOX in multiple myeloma (MM). In patients with MM, NBEA and WWOX are frequently involved in chromosomal deletion at 13q14 and 16q23, respectively. In acute myeloid leukemia, novel fusion RNAs, PVT1-NSMCE2 and CCDC26-NSMCE2, were identified in association with marker chromosomes and double minute chromosomes derived from chromosome 8 showing 8q24 amplicons. Chromothripsis is a possible cytogenetic mechanism of generating PVT1-NSMCE2 and CCDC26-NSMCE2. As PVT1 and CCDC26 are long intergenic non-coding RNAs (lincRNAs), our study suggests that the fusion genes involving lincRNAs potentially play as-yet-unknown oncogenic functional roles. Advancements in molecular cytogenetic techniques along with next generation sequencing will facilitate the understanding of tumorigenesis in hematological malignancies.

Save Icon
Up Arrow
Open/Close
  • Ask R Discovery Star icon
  • Chat PDF Star icon

AI summaries and top papers from 250M+ research sources.